Scott B Perlman - JoVE Visualize

Showing results (41-50 of 48) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 48 results.

Arxiv|April 25, 2024

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation NetworkXin Tie, Muheon Shin, Changhee Lee, et al.

Radiology. Artificial Intelligence|February 19, 2025

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation NetworkXin Tie, Muheon Shin, Changhee Lee, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020

Exploring Spatial-Temporal Changes in <sup>18</sup>F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With EnzalutamideChristos E Kyriakopoulos, Elisabeth I Heath, Anna Ferrari, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026

Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 TrialXin Tie, Changhee Lee, Scott B Perlman, et al.

EJNMMI Physics|July 15, 2026

Image optimization for low-dose <sup>18</sup>F-FDG breast PET/MRI using deep learning: a pilot studyQuinton J Keigley, Leah C Henze Bancroft, Kelley Salem, et al.

Prostate Cancer and Prostatic Diseases|November 11, 2018

Quantification of bone flare on <sup>18</sup>F-NaF PET/CT in metastatic castration-resistant prostate cancerAmy J Weisman, Stephanie A Harmon, Timothy G Perk, et al.

Leukemia & Lymphoma|November 12, 2025

Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.

Clinical Breast Cancer|January 17, 2025

A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Sergey Tarima, et al.

Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 48 results.

Arxiv|April 25, 2024

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation NetworkXin Tie, Muheon Shin, Changhee Lee, et al.

Radiology. Artificial Intelligence|February 19, 2025

Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation NetworkXin Tie, Muheon Shin, Changhee Lee, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020

Exploring Spatial-Temporal Changes in <sup>18</sup>F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated With EnzalutamideChristos E Kyriakopoulos, Elisabeth I Heath, Anna Ferrari, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026

Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 TrialXin Tie, Changhee Lee, Scott B Perlman, et al.

EJNMMI Physics|July 15, 2026

Image optimization for low-dose <sup>18</sup>F-FDG breast PET/MRI using deep learning: a pilot studyQuinton J Keigley, Leah C Henze Bancroft, Kelley Salem, et al.

Prostate Cancer and Prostatic Diseases|November 11, 2018

Quantification of bone flare on <sup>18</sup>F-NaF PET/CT in metastatic castration-resistant prostate cancerAmy J Weisman, Stephanie A Harmon, Timothy G Perk, et al.

Leukemia & Lymphoma|November 12, 2025

Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)Robert Jeraj, Fenghai Duan, Ryan J Mattison, et al.

Clinical Breast Cancer|January 17, 2025

A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast CancerSailaja Kamaraju, Amy M Fowler, Sergey Tarima, et al.

Pageof 5